REG3G Protein
Overview
REG3G (Regenerating Islet-Derived Protein 3 Gamma), also known as HREV107-1, PAP (Pancreatitis-Associated Protein), or Lithostathine-Related Protein, is a small secreted protein belonging to the regenerating (REG) protein family. This ~16 kDa protein is encoded by the REG3G gene located on chromosome 2q31.1 in humans. Originally identified in pancreatic islet cells and subsequently in various tissues including the immune system and nervous system, REG3G has emerged as an important player in neuroinflammation and neurodegeneration. The protein exists as a multimeric complex and demonstrates both pro-inflammatory and cytoprotective properties depending on cellular context and target cell populations.
Function and Biology
REG3G functions primarily as a secreted effector molecule involved in immune regulation and tissue homeostasis. The protein is constitutively expressed by myeloid cells, particularly microglia and macrophages, where it serves as a damage-associated molecular pattern (DAMP) and immune mediator. REG3G operates through multiple mechanisms: it can directly interact with bacterial lipopolysaccharides (LPS), activate pattern recognition receptors, and modulate immune cell responses. At the molecular level, REG3G exhibits bactericidal activity through direct killing of gram-positive bacteria and certain gram-negative organisms, functioning as part of the innate immune system's first line of defense.
...REG3G Protein
Overview
REG3G (Regenerating Islet-Derived Protein 3 Gamma), also known as HREV107-1, PAP (Pancreatitis-Associated Protein), or Lithostathine-Related Protein, is a small secreted protein belonging to the regenerating (REG) protein family. This ~16 kDa protein is encoded by the REG3G gene located on chromosome 2q31.1 in humans. Originally identified in pancreatic islet cells and subsequently in various tissues including the immune system and nervous system, REG3G has emerged as an important player in neuroinflammation and neurodegeneration. The protein exists as a multimeric complex and demonstrates both pro-inflammatory and cytoprotective properties depending on cellular context and target cell populations.
Function and Biology
REG3G functions primarily as a secreted effector molecule involved in immune regulation and tissue homeostasis. The protein is constitutively expressed by myeloid cells, particularly microglia and macrophages, where it serves as a damage-associated molecular pattern (DAMP) and immune mediator. REG3G operates through multiple mechanisms: it can directly interact with bacterial lipopolysaccharides (LPS), activate pattern recognition receptors, and modulate immune cell responses. At the molecular level, REG3G exhibits bactericidal activity through direct killing of gram-positive bacteria and certain gram-negative organisms, functioning as part of the innate immune system's first line of defense.
In the central nervous system (CNS), REG3G is produced primarily by activated microglia—the brain's resident immune cells—and to a lesser extent by astrocytes. Its expression is tightly regulated by inflammatory stimuli, particularly interferon-gamma (IFN-γ) and lipopolysaccharide (LPS), which upregulate REG3G transcription through JAK-STAT and NF-κB signaling pathways. The protein can be detected in cerebrospinal fluid (CSF) during neuroinflammatory conditions, making it a potential biomarker for CNS inflammation.
Role in Neurodegeneration
REG3G has been implicated in several neurodegenerative diseases, where its role appears context-dependent and disease-stage specific. In Alzheimer's disease (AD), elevated REG3G levels correlate with microglial activation and amyloid-beta (Aβ) pathology. Studies have demonstrated that REG3G expression increases in response to Aβ and tau pathology, representing a marker of neuroinflammatory escalation. Similarly, in Parkinson's disease (PD), REG3G elevation accompanies α-synuclein-induced microglial activation and dopaminergic neuronal loss.
In amyotrophic lateral sclerosis (ALS), REG3G has been identified as part of a neuroinflammatory signature associated with disease progression. Mouse models of ALS show increased REG3G expression in spinal cord microglia, and human CSF samples from ALS patients demonstrate elevated REG3G levels correlating with disease severity. In frontotemporal dementia (FTD) and other tauopathies, REG3G expression rises concordantly with tau pathology and neuronal degeneration.
Molecular Mechanisms
REG3G contributes to neurodegeneration through multiple interconnected pathways. First, as a secreted immune mediator, REG3G activates microglial NLRP3 inflammasome signaling, promoting IL-1β and IL-18 secretion—key pro-inflammatory cytokines that amplify neuroinflammation and promote neuronal damage. Second, REG3G can directly interact with neuronal surfaces, potentially triggering complement activation and antibody-dependent cellular phagocytosis of stressed neurons. Third, REG3G activates pattern recognition receptors including TLR4 and formyl-peptide receptors (FPR), perpetuating microglial activation cycles.
Additionally, REG3G participates in the amplification of neuroinflammatory loops by promoting further recruitment and activation of myeloid cells to CNS lesions. The protein inhibits the production of anti-inflammatory cytokines like IL-10 and TGF-β, shifting the microglial phenotype toward pro-inflammatory (M1) polarization. This phenotypic shift exacerbates neuronal death through enhanced production of reactive oxygen species (ROS), proteases, and toxic mediators.
Clinical and Research Significance
REG3G serves as both a mechanistic target and biomarker in neurodegeneration research. Its elevation in CSF and blood has potential diagnostic utility for identifying patients with active neuroinflammation. Therapeutic targeting of REG3G or its signaling pathways represents a novel strategy for modulating excessive microglial activation. Recent studies suggest that REG3G inhibition or functional antagonism could reduce neuroinflammatory burden in preclinical models of neurodegeneration.
Related proteins include other REG family members (REG1A, REG1B, REG3A), the complement system, NLRP3 inflammasome components, pro-inflammatory cytokines (IL-1β, TNF-α